Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get Started
close window
Housecall Archives
About our e-newsletters
- Free e-newsletters
- Mayo Clinic expertise
- We do not share your e-mail address
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific e-newsletters also include blogs, questions and answers with Mayo Clinic experts, and other useful information that will help you manage your health.
Housecall Archives
close window
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Risk factors
By Mayo Clinic staffIn general, people at greatest risk of SARS have had direct, close contact with someone who's infected, such as:
- A roommate or family member.
- Doctors and hospital workers who treated people with SARS before the disease was identified were some of the first SARS casualties.
- People with a variation in an immune system gene that may make them much more vulnerable to the SARS virus. The genetic variation is common among people of Southeast Asian descent but is rare in other populations. This may help explain why most SARS cases have occurred in China and Southeast Asia.
References
- Hirsch MS, et al. Severe acute respiratory syndrome (SARS). http://www.uptodate.com/home/index.html. Accessed Nov. 17, 2008.
- Severe acute respiratory syndrome (SARS): Current SARS situation. Centers for Disease Control and Prevention. http://www.cdc.gov/nciDOD/sars/situation.htm. Accessed Nov. 17, 2008.
- Hui DS, et al. Current features, pathogenesis and immunobiology of severe acute respiratory syndrome. Current Opinion in Pulmonary Medicine. 2008;14:241.
- Severe acute respiratory syndrome: Frequently asked questions about SARS. Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/sars/faq.htm. Accessed Nov. 18, 2008.
- Frequently asked questions on severe acute respiratory syndrome (SARS). World Health Organization. http://www.who.int/csr/sars/sarsfaq/en. Accessed Nov. 18, 2008.
- Clinical, epidemiologic, and virologic features of SARS-CoV. Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/sars/guidance/core/app1.htm. Accessed Nov. 19, 2008.
- Tansey CM, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Archives of Internal Medicine. 2007;167:1312.
- Wong SS, et al. The management of coronavirus infections with particular reference to SARS. Journal of Antimicrobial Chemotherapy. 2008;62:437.
- Severe acute respiratory syndrome (SARS). Supplement F: Laboratory guidance. Diagnostic assays. Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/sars/guidance/F/assays.htm. Accessed Nov. 19, 2008.
- Chu CM, et al. Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax. 2004;59:252.
- Guidance about severe acute respiratory syndrome (SARS) for persons traveling to areas where SARS cases have been reported. Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/sars/travel_advice.htm. Accessed Nov. 25, 2008.
- Stockman LJ, et al. Severe acute respiratory syndrome in children. The Pediatric Infectious Disease Journal. 2007;26:68.
